Proper Utilization Of A Wealth Of Healthcare Data Can Solve Clinical Research's Enrollment Struggles

The FDA recently released new guidance on using electronic health record (EHR) data in drug and biologic clinical trials. This 35-page document is timely because there is now more EHR data available than ever before.

This abundance of healthcare data holds great promise for streamlining clinical research and one of the first areas of promise is the opportunity it provides for researchers to efficiently find patients for studies, regardless of the study protocol.